Policy reforms like the National Pharmaceutical Policy and initiatives such as the Production Linked Incentive (PLI) are fueling innovation and attracting further investment.

As the third-largest producer of pharmaceutical products by volume, and the 14th by value, India exports medicines to over 200 countries. It supplies more than half of Africa's generic drugs, 40% of the United States' generic needs, and 25% of the UK's pharmaceutical demand.

India is also the world leader in vaccine production, holding a 60% market share and supplying 40–70% of the WHO’s demand for DPT, BCG, and measles vaccines. The country also provides 20% of the global supply of generic medicines by volume. With strong support from its scientific and technological base, growing government backing, and a robust domestic market, India’s pharmaceutical industry continues to contribute significantly to the nation’s economic growth and employment generation.